Biotoxtech Co., Ltd. (KOSDAQ:086040)

Biotoxtech Statistics

Total Valuation

Biotoxtech has a market cap or net worth of KRW 50.15 billion. The enterprise value is 78.64 billion.

Market Cap	50.15B
Enterprise Value	78.64B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotoxtech has 15.72 million shares outstanding. The number of shares has decreased by -1.13% in one year.

Current Share Class	15.72M
Shares Outstanding	15.72M
Shares Change (YoY)	-1.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.74%
Owned by Institutions (%)	n/a
Float	10.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.16
PB Ratio	1.64
P/TBV Ratio	1.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.49
EV / Sales	1.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.37

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 2.07.

Current Ratio	0.63
Quick Ratio	0.42
Debt / Equity	2.07
Debt / EBITDA	n/a
Debt / FCF	-11.55
Interest Coverage	-1.27

Financial Efficiency

Return on equity (ROE) is -29.82% and return on invested capital (ROIC) is -4.43%.

Return on Equity (ROE)	-29.82%
Return on Assets (ROA)	-3.22%
Return on Invested Capital (ROIC)	-4.43%
Return on Capital Employed (ROCE)	-14.53%
Revenue Per Employee	230.91M
Profits Per Employee	-31.00M
Employee Count	188
Asset Turnover	0.32
Inventory Turnover	3.48

Taxes

In the past 12 months, Biotoxtech has paid 3.62 billion in taxes.

Income Tax	3.62B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.67% in the last 52 weeks. The beta is 0.87, so Biotoxtech's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-25.67%
50-Day Moving Average	2,999.80
200-Day Moving Average	3,061.48
Relative Strength Index (RSI)	61.13
Average Volume (20 Days)	54,991

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotoxtech had revenue of KRW 43.41 billion and -5.83 billion in losses. Loss per share was -403.18.

Revenue	43.41B
Gross Profit	4.08B
Operating Income	-6.88B
Pretax Income	-7.26B
Net Income	-5.83B
EBITDA	-2.65B
EBIT	-6.88B
Loss Per Share	-403.18

Balance Sheet

The company has 27.68 billion in cash and 63.21 billion in debt, giving a net cash position of -35.53 billion or -2,260.24 per share.

Cash & Cash Equivalents	27.68B
Total Debt	63.21B
Net Cash	-35.53B
Net Cash Per Share	-2,260.24
Equity (Book Value)	30.57B
Book Value Per Share	2,392.17
Working Capital	-31.16B

Cash Flow

In the last 12 months, operating cash flow was -3.61 billion and capital expenditures -1.87 billion, giving a free cash flow of -5.47 billion.

Operating Cash Flow	-3.61B
Capital Expenditures	-1.87B
Free Cash Flow	-5.47B
FCF Per Share	-348.14

Margins

Gross margin is 9.40%, with operating and profit margins of -15.86% and -13.43%.

Gross Margin	9.40%
Operating Margin	-15.86%
Pretax Margin	-16.73%
Profit Margin	-13.43%
EBITDA Margin	-6.09%
EBIT Margin	-15.86%
FCF Margin	n/a

Dividends & Yields

Biotoxtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.13%
Shareholder Yield	n/a
Earnings Yield	-11.62%
FCF Yield	-10.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotoxtech has an Altman Z-Score of 0.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.19
Piotroski F-Score	4